Ronald McCoy
Internal Medicine · Muscle Shoals, ALNPI 1386706752
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Novo Nordisk at 27.3% of the total. Reporting peaked in 2019 at $2,605 and has fallen 99.5% since, to $12 in 2022.
Across 201 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$904
- Amarin Pharma, Inc.$396
- Johnson & Johnson$380
- Pfizer$229
- Esperion Therapeutics, Inc.$208
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,84799%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 57 | $1,332 |
| AstraZeneca | 17 | $904 |
| Amarin Pharma, Inc. | 18 | $396 |
| Johnson & Johnson | 21 | $380 |
| Pfizer | 14 | $229 |
| Esperion Therapeutics, Inc. | 2 | $208 |
| Amgen | 6 | $159 |
| Teva Pharmaceuticals USA, Inc. | 6 | $157 |
| Boehringer Ingelheim | 12 | $155 |
| Merck | 3 | $131 |
| Lilly USA, LLC | 3 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $87 |
| Sanofi-aventis U.S. LLC | 1 | $87 |
| AbbVie(2 entities) | 7 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $81 |
| Novartis | 4 | $61 |
| Roche Diagnostics Corporation | 1 | $50 |
| Eisai Inc. | 4 | $47 |
| Ironwood Pharmaceuticals, Inc | 3 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 2 | $28 |
| Daiichi Sankyo Inc. | 2 | $27 |
| GSK | 2 | $25 |
| Genentech USA, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Bausch Health US, LLC | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
| Assertio Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,877 in reported general payments places this provider in the 85th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Muscle Shoals
- Loren McCoyMuscle Shoals$48K
- Ryan WeldonBirmingham$458K
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Robert LewisBirmingham$187K
- Rosalind BowlesGadsden$168K
- Sonja PettusJasper$117K
- Bobby WrightsMobile$89K
- Thomas HuddleBirmingham$76K
- Rahel AzizMobile$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.